Predictors of diagnostic delay in amyotrophic lateral sclerosis: a cohort study based on administrative and electronic medical records data

References

• Belsh JM, Schiffman PL. The amyotrophic lateral sclerosis (ALS) patient perspective on misdiagnosis and its repercussions. J Neurol Sci. 1996;139: 110–6.
   PubMed Web of Science ®Google Scholar
• Iwasaki Y, Ikeda K, Kinoshita M. The diagnostic pathway in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001;2:123–6.
   PubMed Web of Science ®Google Scholar
• Westeneng HJ, Debray TPA, Visser AE, van Eijk RPA, Rooney JPK, Calvo A, et al. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol. 2018;17:423–33.
   PubMed Web of Science ®Google Scholar
• Nzwalo H, de Abreu D, Swash M, Pinto S, de Carvalho M. Delayed diagnosis in ALS: the problem continues. J Neurol Sci. 2014;343:173–5.
   PubMed Web of Science ®Google Scholar
• Househam E, Swash M. Diagnostic delay in amyotrophic lateral sclerosis: what scope for improvement? J Neurol Sci. 2000;180:76–81.
   PubMed Web of Science ®Google Scholar
• Cellura E, Spataro R, Taiello AC, La Bella V. Factors affecting the diagnostic delay in amyotrophic lateral sclerosis. Clin Neurol Neurosurg. 2012;114:550–4.
   PubMed Web of Science ®Google Scholar
• Geevasinga N, Loy CT, Menon P, de Carvalho M, Swash M, Schrooten M, et al. Awaji criteria improves the diagnostic sensitivity in amyotrophic lateral sclerosis: a systematic review using individual patient data. Clin Neurophysiol. 2016;127:2684–91.
   PubMed Web of Science ®Google Scholar
• Ghasemi M. Amyotrophic lateral sclerosis mimic syndromes. Iran J Neurol. 2016;15:85–91.
   PubMed Web of Science ®Google Scholar
• Chiò A. ISIS Survey: an international study on the diagnostic process and its implications in amyotrophic lateral sclerosis. J Neurol. 1999;246: III1–5.
   PubMed Web of Science ®Google Scholar
• Kraemer M, Buerger M, Berlit P. Diagnostic problems and delay of diagnosis in amyotrophic lateral sclerosis. Clin Neurol Neurosurg. 2010;112:103–5.
   PubMed Web of Science ®Google Scholar
• Galvin M, Ryan P, Maguire S, Heverin M, Madden C, Vajda A, et al. The path to specialist multidisciplinary care in amyotrophic lateral sclerosis: a population-based study of consultations, interventions and costs. PLoS One. 2017;12:e0179796.
   PubMed Web of Science ®Google Scholar
• Marin B, Boumédiene F, Logroscino G, Couratier P, Babron MC, Leutenegger AL, et al. Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. Int J Epidemiol. 2017;46:57–74.
   PubMed Web of Science ®Google Scholar
• Paganoni S, Macklin EA, Lee A, Murphy A, Chang J, Zipf A, et al. Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS). Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:453–6.
   PubMed Web of Science ®Google Scholar
• Pinto S, Swash M, de Carvalho M. Does surgery accelerate progression of amyotrophic lateral sclerosis? J Neurol Neurosurg Psychiatry. 2014;85:643–6.
   PubMed Web of Science ®Google Scholar
• Riviere M, Meininger V, Zeisser P, Munsat T. An analysis of extended survival in patients with amyotrophic lateral sclerosis treated with riluzole. Arch Neurol. 1998;55:526–8.
   PubMed Web of Science ®Google Scholar
• Writing G. and for the Edaravone (MCI-186) ALS 19 study group. Safety and efficacy of edaravone in well-defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2017;16:505–12.
   PubMed Web of Science ®Google Scholar
• Abe K, Itoyama Y, Sobue G, Tsuji S, Aoki M, Doyu M, et al. Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:610–7.
   PubMed Web of Science ®Google Scholar
• Oh KW, Moon C, Kim HY, Oh SI, Park J, Lee JH, et al. Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis. Stem Cells. 2015;4:590–7.
   Web of Science ®Google Scholar
• Hamidou B, Marin B, Lautrette G, Nicol M, Camu W, Corcia P, et al. Exploring the diagnosis delay and ALS functional impairment at diagnosis as relevant criteria for clinical trial enrolment. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:519–27.
   PubMed Web of Science ®Google Scholar
• Zoccolella S, Beghi E, Palagano G, Fraddosio A, Samarelli V, Lamberti P, et al. Signs and symptoms at diagnosis of amyotrophic lateral sclerosis: a population-based study in southern Italy. Eur J Neurol. 2006;13:789–92.
   PubMed Web of Science ®Google Scholar
• ISTAT. Available at: http://demo.istat.it/pop2014/index.html. Accessed April 20, 2018.
   Google Scholar
• Palese F, Sartori A, Verriello L, Ros S, Passadore P, Manganotti P, et al. Epidemiology of amyotrophic lateral sclerosis in Friuli-Venezia Giulia, north-eastern Italy, 2002–2014: a retrospective population based study. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:1–10.
   PubMed Web of Science ®Google Scholar
• Rothman K, Greenland S, eds. Modern epidemiology. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 1998:205–207.
   Google Scholar
• http://www.who.int/news-room/fact-sheets/detail/ageing-and-health. Accessed September 26, 2018.
   Google Scholar
• Belsh JM, Schiffman PL. Misdiagnosis in patients with amyotrophic lateral sclerosis. Arch Intern Med. 1990;150:2301–5.
   PubMed Web of Science ®Google Scholar
• Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Amyotrophic lateral sclerosis mimic syndromes: a population-based study. Arch Neurol. 2000;57:109–13.
   PubMed Web of Science ®Google Scholar
• Donaghy C, Dick A, Hardiman O, Patterson V. Timeliness of diagnosis in motor neurone disease: a population-based study. Ulster Med J. 2008;77:18–21.
   PubMedGoogle Scholar
• Khishchenko N, Allen KD, Coffman CJ, Kasarskis EJ, Lindquist JH, Morgenlander JC, et al. Time to diagnosis in the national registry of veterans with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010;11:125–32.
   PubMed Web of Science ®Google Scholar
• Mitchell JD, Callagher P, Gardham J, Mitchell C, Dixon M, Addison-Jones R, et al. Timelines in the diagnostic evaluation of people with suspected amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)-a 20-year review: can we do better? Amyotroph Lateral Scler. 2010;11:537–41.
   PubMed Web of Science ®Google Scholar
• Williams TL. Motor neurone disease: diagnostic pitfalls. Clin Med (Lond). 2013;13:97–100.
   PubMed Web of Science ®Google Scholar
• Bakola E, Kokotis P, Zambelis T, Karandreas N. Inappropriate surgeries in amyotrophic lateral sclerosis: a still considerable issue. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:315–7.
   PubMed Web of Science ®Google Scholar
• Jordan H, Fagliano J, Rechtman L, Lefkowitz D, Kaye W. Population-based surveillance of amyotrophic lateral sclerosis in New Jersey, 2009–2011. Neuroepidemiology. 2014;43:49–56.
   PubMed Web of Science ®Google Scholar
• Vázquez-Costa JF, Martínez-Molina M, Fernández-Polo M, Fornés-Ferrer V, Frasquet-Carrera M, Sevilla-Mantecón T. Analysis of the diagnostic pathway and delay in patients with amyotrophic lateral sclerosis in the Valencian community. Neurologia. 2018;pii: S0213–4853(18):30157–9.
   PubMed Web of Science ®Google Scholar
• Gordon PH. Amyotrophic lateral sclerosis: an update for 2013 clinical features, pathophysiology, management and therapeutic trials. Aging Dis. 2013;04:295–310.
   Google Scholar
• Ragonese P, Cellura E, Aridon P, D’amelio M, Spataro R, Taiello AC, et al. Incidence of amyotrophic lateral sclerosis in Sicily: a population based study. Amyotroph Lateral Scler. 2012;13:284–7.
   PubMed Web of Science ®Google Scholar
• Pugliatti M, Parish LD, Cossu P, Leoni S, Ticca A, Saddi MV, et al. Amyotrophic lateral sclerosis in Sardinia, insular Italy, 1995–2009. J Neurol. 2013;260:572–9.
   PubMed Web of Science ®Google Scholar
• Logroscino G, Beghi E, Zoccolella S, Palagano R, Fraddosio A, Simone IL, et al. SLAP registry. Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study. J Neurol Neurosurg Psychiatry. 2005;76:1094–8.
   PubMed Web of Science ®Google Scholar
• Scialò C, Novi G, Bandettini di Poggio M, Canosa A, Sormani MP, Mandich P, et al. Clinical epidemiology of amyotrophic lateral sclerosis in Liguria, Italy: an update of LIGALS register. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:535–42.
   PubMed Web of Science ®Google Scholar
• Mandrioli J, Biguzzi S, Guidi C, Venturini E, Sette E, Terlizzi E, et al. Epidemiology of amyotrophic lateral sclerosis in Emilia-Romagna Region (Italy): a population based study. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:262–8.
   PubMed Web of Science ®Google Scholar
• http://www.quotidianosanita.it/studi-e-analisi/articolo.php?articolo_id=57941. Accessed April 20, 2018.
   Google Scholar
• Vu LT, Bowser R. Fluid-based biomarkers for amyotrophic lateral sclerosis. Neurotherapeutics. 2017;14:119–34.
   PubMed Web of Science ®Google Scholar
• Cristini J. Misdiagnosis and missed diagnoses in patients with ALS. JAAPA. 2006;19:29–35.
   PubMedGoogle Scholar
• Srinivasan J, Scala S, Jones HR, Saleh F, Russell JA. Inappropriate surgeries resulting from misdiagnosis of early amyotrophic lateral sclerosis. Muscle Nerve. 2006;34:359–60.
   PubMed Web of Science ®Google Scholar
• https://www.gponline.com/clinical-review-motor-neurone-disease/neurology/article 1328434. Accessed September 26, 2018.
   Google Scholar